Quick Answer
SkinHealth Systems Inc. reported Stockholders Equity of $61.06 million for the year ending 2025.
- SkinHealth Systems Inc. showed an increase of +17.9% in Stockholders Equity from 2024 to 2025.
- This data is from SkinHealth Systems Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$10.32 million | Q2 2020: -$20.51 million | Q3 2020: -$22.54 million | Q1 2021: -$33.21 million | Q2 2021: $16.07 million | Q3 2021: -$142.06 million | Q1 2022: $336.39 million | Q2 2022: $345.41 million | Q3 2022: $250.77 million | Q1 2023: $152.41 million | Q2 2023: $161.84 million | Q3 2023: $89.96 million | Q1 2024: $63.30 million | Q2 2024: $69.19 million | Q3 2024: $59.72 million | Q1 2025: $46.06 million | Q2 2025: $74.00 million | Q3 2025: $65.66 million.
- Over the full 8 years of available data (2018 to 2025), SkinHealth Systems Inc.'s Stockholders Equity has grown by 20,667.3%.
- Historical annual values: Fiscal year 2025: $61.06 million | Fiscal year 2024: $51.80 million | Fiscal year 2023: $59.39 million | Fiscal year 2022: $167.05 million | Fiscal year 2021: $298.03 million | Fiscal year 2020: -$30.57 million | Fiscal year 2019: -$1.21 million | Fiscal year 2018: $294.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: